Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Apr 7, 2005; 11(13): 1987-1990
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.1987
Published online Apr 7, 2005. doi: 10.3748/wjg.v11.i13.1987
HCC | LC | CH | CRF | CHF | IBD | Controls | |
Number of patients | 54 | 132 | 45 | 36 | 27 | 45 | 75 |
Male/female | 39/15 | 93/39 | 30/15 | 18/18 | 12/15 | 30/15 | 51/24 |
Age (yr) | 69±11 | 59±12 | 52±13 | 71±17 | 72±15 | 45±6 | 48±15 |
CgA (ng/mL) | 769±1 046 | 249±369 | 87±94 1 | 390±1 401 | 577±539 | 146±287 | 48±18 |
α-FP (ng/mL) | 79±160 | 10±13 | |||||
Child–Pugh class | |||||||
A | 12 | 36 | |||||
B | 15 | 57 | |||||
C | 27 | 39 |
- Citation: Spadaro A, Ajello A, Morace C, Zirilli A, D’arrigo G, Luigiano C, Martino F, Bene A, Migliorato D, Turiano S, Ferraù O, Freni MA. Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits. World J Gastroenterol 2005; 11(13): 1987-1990
- URL: https://www.wjgnet.com/1007-9327/full/v11/i13/1987.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i13.1987